Comparing Advanced Biomedical Technologies (OTCMKTS:ABMT) & Sanara MedTech (NASDAQ:SMTI)
Comparing Advanced Biomedical Technologies (OTCMKTS:ABMT) & Sanara MedTech (NASDAQ:SMTI)
Advanced Biomedical Technologies (OTCMKTS:ABMT – Get Rating) and Sanara MedTech (NASDAQ:SMTI – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, dividends, profitability, institutional ownership, risk, analyst recommendations and valuation.
Advanced Biomedicale Technologies（OTCMKTS: ABMT — 獲取評級）和薩納拉醫療科技（納斯達克股票代碼：SMTI — 獲取評級）都是小型醫療公司，但哪家業務更勝一籌？我們將根據兩家企業的收益、股息、盈利能力、機構所有權、風險、分析師建議和估值對比這兩家企業。
Profitability
盈利能力
This table compares Advanced Biomedical Technologies and Sanara MedTech's net margins, return on equity and return on assets.
該表比較了先進的生物醫學技術公司和Sanara MedTech的淨利潤率、股本回報率和資產回報率。
| Net Margins | Return on Equity | Return on Assets | |
| Advanced Biomedical Technologies | N/A | N/A | N/A |
| Sanara MedTech | -26.07% | -31.80% | -23.56% |
| 淨利潤 | 股本回報率 | 資產回報率 | |
| 先進的生物醫學技術 | 不適用 | 不適用 | 不適用 |
| 薩納拉醫療科技 | -26.07% | -31.80% | -23.56% |
Institutional & Insider Ownership
機構和內部所有權
4.0% of Sanara MedTech shares are held by institutional investors. 34.1% of Advanced Biomedical Technologies shares are held by company insiders. Comparatively, 58.4% of Sanara MedTech shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Sanara MedTech的4.0％股票由機構投資者持有。34.1％的Advanced Biomedical Technologies股票由公司內部人士持有。相比之下，Sanara MedTech的股票中有58.4％由公司內部人士持有。強大的機構所有權表明大型基金經理、對沖基金和捐贈基金認爲一家公司有望實現長期增長。
Valuation & Earnings
估值與收益
This table compares Advanced Biomedical Technologies and Sanara MedTech's revenue, earnings per share (EPS) and valuation.
該表比較了先進生物醫學技術公司和Sanara MedTech的收入、每股收益（EPS）和估值。
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Advanced Biomedical Technologies | $120,000.00 | 28.89 | -$670,000.00 | N/A | N/A |
| Sanara MedTech | $45.84 million | 8.62 | -$7.94 million | ($1.52) | -31.04 |
| 總收入 | 價格/銷售比率 | 淨收入 | 每股收益 | 市盈率 | |
| 先進的生物醫學技術 | 120,000.00 美元 | 28.89 | -670,000.00 美元 | 不適用 | 不適用 |
| 薩納拉醫療科技 | 4584 萬美元 | 8.62 | -794 萬美元 | (1.52 美元) | -31.04 |
Advanced Biomedical Technologies has higher earnings, but lower revenue than Sanara MedTech.
與Sanara MedTech相比，先進生物醫學技術的收益更高，但收入更低。
Volatility & Risk
波動性與風險
Advanced Biomedical Technologies has a beta of 0.69, meaning that its share price is 31% less volatile than the S&P 500. Comparatively, Sanara MedTech has a beta of 1.81, meaning that its share price is 81% more volatile than the S&P 500.
Advanced BiomedicalTechnologies的beta值爲0.69，這意味着其股價的波動性比標準普爾500指數低31％。相比之下，Sanara MedTech的beta值爲1.81，這意味着其股價的波動性比標準普爾500指數高81％。
Analyst Recommendations
分析師建議
This is a summary of recent ratings and target prices for Advanced Biomedical Technologies and Sanara MedTech, as reported by MarketBeat.
這是MarketBeat報道的Advanced Biomedical Technologies和Sanara MedTech最近的評級和目標價格的摘要。
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Advanced Biomedical Technologies | 0 | 0 | 0 | 0 | N/A |
| Sanara MedTech | 0 | 0 | 1 | 0 | 3.00 |
| 賣出評級 | 持有評級 | 買入評級 | 強勁的買入評級 | 評分分數 | |
| 先進的生物醫學技術 | 0 | 0 | 0 | 0 | 不適用 |
| 薩納拉醫療科技 | 0 | 0 | 1 | 0 | 3.00 |
Sanara MedTech has a consensus target price of $50.00, suggesting a potential upside of 5.98%. Given Sanara MedTech's higher probable upside, analysts plainly believe Sanara MedTech is more favorable than Advanced Biomedical Technologies.
Sanara MedTech的共識目標價格爲50.00美元，表明潛在的上漲空間爲5.98％。鑑於Sanara MedTech可能有更高的上行空間，分析師顯然認爲Sanara MedTech比先進的生物醫學技術更有利。
Summary
摘要
Sanara MedTech beats Advanced Biomedical Technologies on 6 of the 11 factors compared between the two stocks.
在這兩隻股票比較的11個因素中，Sanara MedTech在6個因素上擊敗了先進生物醫學技術。
About Advanced Biomedical Technologies
關於先進的生物醫學技術
(Get Rating)
（獲取評級）
Advanced BioMedical Technologies, Inc. engages in the provision of medical and pain management tools. Its products include Electro-Acuscope 85P (Portable), Electro-Acuscope 80L, Neuroscope 230B, Electro-Myopulse 75L (Base Model), Electro-Myopulse 75F (Used in Fermi Lab Study), and Electro-Myopulse EMS 85P (Portable). The company was founded in 1984 and is headquartered in New York, NY.
Advanced BioMedial Technologies, Inc. 從事醫療和疼痛其產品包括 Electro-Acuscope 85P（便攜式）、Electro-Acuscope 80L、Neuroscope 230B、Electro-Myopulse 75L（基本型號）、Electro-Myopulse 75F（用於費米實驗室研究）和 Electro-Myopulse EMS 85P（便攜式）。該公司成立於1984年，總部位於紐約州紐約。
About Sanara MedTech
關於 Sanara MedTech
(Get Rating)
（獲取評級）
Sanara MedTech, Inc.engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. It offers CellerateRX Surgical Activated Collagen Adjuvant and HemaQuell Resorbable Bone Hemostat. The company was founded in 1982 and is headquartered in Fort Worth, TX.
Sanara MedTech, Inc. 從事生物技術產品的開發、營銷和分銷給醫生、醫院和診所。它提供 celleRaterX 手術活化膠原蛋白佐劑和 HemaQuell 可吸收的骨止血藥。該公司成立於1982年，總部位於德克薩斯州沃思堡。
Receive News & Ratings for Advanced Biomedical Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Biomedical Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
每日接收先進生物醫學技術的新聞和收視率 -在下面輸入您的電子郵件地址，以通過Marketbeat.com的免費每日電子郵件時事通訊接收Advanced Biomedical Technologies和相關公司的最新新聞和分析師評級的簡明每日摘要。
譯文內容由第三人軟體翻譯。